Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease

被引:2
|
作者
Sharipova, D. V. [1 ,2 ,3 ]
Kovalenko, V. R. [1 ]
Bairamova, E. M. [1 ,3 ]
Vartanova, V. A. [1 ,3 ]
Grigor'eva, E. V. [1 ,2 ,3 ]
Vyatkin, Y. V. [3 ,5 ,6 ]
Khabarova, E. A. [4 ]
Rzaev, D. A. [4 ]
Zakian, S. M. [1 ,2 ,3 ]
Medvedev, S. P. [1 ,2 ,3 ]
机构
[1] Russian Acad Sci, Siberian Branch, Fed Res Ctr, Inst Cytol & Genet, Novosibirsk, Russia
[2] Minist Hlth Russian Federat, EN Meshalkin Natl Med Res Ctr, Novosibirsk, Russia
[3] Novosibirsk State Univ, Novosibirsk, Russia
[4] Fed Neurosurg Ctr, Novosibirsk, Russia
[5] AcademGene LLC, Novosibirsk, Russia
[6] St Laurent Inst, Woburn, MA USA
基金
俄罗斯科学基金会;
关键词
D O I
10.1016/j.scr.2019.101652
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Studying Parkinson's disease (PD), one of the most common neurodegenerative disorders worldwide, requires different model systems, including patient-specific induced pluripotent stem cell lines. With the help of non-integrating episomal vectors the iPSC lines ICGi015-A and ICGi015-B were generated from blood mononuclear cells of PD patient, carrying three SNPs, associated with PD development. The obtained iPSC lines express pluripotency markers and demonstrate the ability to in vitro differentiate into the three germ layers. These cell lines may be useful for studying molecular mechanisms of PD and for drug screening.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease
    Grigor'eva, E., V
    Malankhanova, T. B.
    Surumbayeva, A.
    Minina, J. M.
    Morozov, V. V.
    Abramycheva, N. Yu
    Illarioshkin, S. N.
    Malakhova, A. A.
    Zakian, S. M.
    STEM CELL RESEARCH, 2019, 34
  • [2] Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7
    Dementyeva, E., V
    Kovalenko, V. R.
    Zhiven, M. K.
    Ustyantseva, E., I
    Kretov, E., I
    Vyatkin, Yu V.
    Zakian, S. M.
    STEM CELL RESEARCH, 2020, 46
  • [3] Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington?s disease
    Grigor'eva, Elena V.
    Malakhova, Anastasia A.
    Sorogina, Diana A.
    Pavlova, Sofia V.
    Malankhanova, Tuyana B.
    Abramycheva, Natalia Yu.
    Klyushnikov, Sergey A.
    Illarioshkin, Sergey N.
    Zakian, Suren M.
    STEM CELL RESEARCH, 2022, 63
  • [4] Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease associated with GBA mutation
    Grigor'eva, Elena, V
    Drozdova, Elena S.
    Sorogina, Diana A.
    Malakhova, Anastasia A.
    Pavlova, Sofia, V
    Vyatkin, Yuri V.
    Khabarova, Elena A.
    Rzaev, Jamil A.
    Medvedev, Sergey P.
    Zakian, Suren M.
    STEM CELL RESEARCH, 2022, 59
  • [5] Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population
    Malakhova, A. A.
    Grigor'eva, E., V
    Pavlova, S., V
    Malankhanova, T. B.
    Valetdinova, K. R.
    Vyatkin, Y. V.
    Khabarova, E. A.
    Rzaev, J. A.
    Zakian, S. M.
    Medvedev, S. P.
    STEM CELL RESEARCH, 2020, 48
  • [6] Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease
    Malakhova, A. A.
    Grigor'eva, E. V.
    Malankhanova, T. B.
    Pavlova, S. V.
    Valetdinova, K. R.
    Abramycheva, N. Yu.
    Vetchinova, A. S.
    Illarioshkin, S. N.
    Zakian, S. M.
    STEM CELL RESEARCH, 2020, 44
  • [7] Creation of Induced Pluripotent Stem Cells ICGi044-B and ICGi044-C Using Reprogramming of Peripheral Blood Mononuclear Cells of a Patient with Parkinson’s Disease Associated with c.1492T>G Mutation in the GLUD2 Gene
    D. A. Sorogina
    E. V. Grigor’eva
    A. A. Malakhova
    S. V. Pavlova
    S. P. Medvedev
    Y. V. Vyatkin
    E. A. Khabarova
    J. A. Rzaev
    S. M. Zakian
    Russian Journal of Developmental Biology, 2023, 54 : 104 - 111
  • [8] Creation of Induced Pluripotent Stem Cells ICGi044-B and ICGi044-C Using Reprogramming of Peripheral Blood Mononuclear Cells of a Patient with Parkinson's Disease Associated with c.1492T>G Mutation in the GLUD2 Gene
    Sorogina, D. A.
    Grigor'eva, E. V.
    Malakhova, A. A.
    Pavlova, S. V.
    Medvedev, S. P.
    Vyatkin, Y. V.
    Khabarova, E. A.
    Rzaev, J. A.
    Zakian, S. M.
    RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2023, 54 (01) : 104 - 111
  • [9] Generation of an Induced Pluripotent Stem Cell Line, ICGi042-A, by Reprogramming Peripheral Blood Mononuclear Cells from a Parkinson’s Disease Patient with c.1000G>A Mutation in the LRRK2 Gene
    E. V. Grigor’eva
    S. V. Pavlova
    A. A. Malakhova
    S. P. Medvedev
    J. M. Minina
    Y. V. Vyatkin
    E. A. Khabarova
    J. A. Rzaev
    L. V. Kovalenko
    S. M. Zakian
    Russian Journal of Developmental Biology, 2023, 54 : 80 - 87
  • [10] Generation of an Induced Pluripotent Stem Cell Line, ICGi043-A, by Reprogramming Peripheral Blood Mononuclear Cells from a Parkinson’s Disease Patient with p.G2019S Mutation in the LRRK2 Gene
    E. V. Grigor’eva
    S. V. Pavlova
    A. A. Malakhova
    E. S. Yarkova
    D. A. Sorogina
    J. M. Minina
    I. V. Miliukhina
    M. A. Nikolaev
    S. N. Pchelina
    S. P. Medvedev
    S. M. Zakian
    Russian Journal of Developmental Biology, 2023, 54 : 72 - 79